Zobrazeno 1 - 10
of 523
pro vyhledávání: '"hybrid immunity"'
Autor:
Memory Mvula, Fatima Mtonga, Jonathan Mandolo, Chisomo Jowati, Alice Kalirani, Precious Chigamba, Edwin Lisimba, Ndaona Mitole, Marah G. Chibwana, Kondwani C. Jambo
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hybrid immunity provides better protection against COVID-19 than vaccination or prior natural infection alone. It induces high magnitude and broadly cross-reactive neutralising anti-Spike IgG antibodies. However, it is not clear h
Externí odkaz:
https://doaj.org/article/05866432303f451aa80e29a42395b319
Autor:
Marina M. Zafranskaya, D. B. Nizheharodava, O. G. Shatova, I. I. Russkih, A. V. Velichko, M. I. Vanslau, S. F. Novitskaya, T. L. Denisevich, M. G. Kolyadko, E. K. Kurlyanskaya
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 3, Pp 443-450 (2024)
Heart transplant patients are at an increased risk of COVID-19 infection adverse outcomes because of underlying immunosuppression and concomitant comorbidities. To date, all large-scale randomized controlled trials for various COVID-19 vaccines have
Externí odkaz:
https://doaj.org/article/2a5b052a37b949d2a9e850855c0cba8d
Autor:
Leah J. Ricketson, Emily J. Doucette, Isabella Alatorre, Tarannum Tarannum, Joslyn Gray, William Booth, Graham Tipples, Carmen Charlton, Jamil N. Kanji, Kevin Fonseca, James D. Kellner
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background There are few reports of longitudinal serologic responses in children following Sars-CoV-2 infection and vaccination. This study describes longitudinal SARS-CoV-2 antibody responses following infection, vaccination, or both (hybri
Externí odkaz:
https://doaj.org/article/ed0d78e0f95b426bb82d1f59deb13464
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT This study aims to investigate humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and assess the impact of booster vaccines. We recruited individuals scheduled to receive either the first (original formula)
Externí odkaz:
https://doaj.org/article/fd715b929e2d459f82b68b12c455ffb9
Autor:
Xuan Ying Poh, I. Russel Lee, Chee Wah Tan, Jean-Marc Chavatte, Siew Wai Fong, Yun Shan Goh, Angeline Rouers, Nathan Wong, Anthony Torres-Ruesta, Shirley Y.Y. Mah, Aileen Y.Y. Yeoh, Mihir Gandhi, Nabilah Rahman, Yi Qing Chin, J. Jonathan Lim, Terence J.K. Yoong, Suma Rao, Po Ying Chia, Sean W.X. Ong, Tau Hong Lee, Sapna P. Sadarangani, Ray J.H. Lin, Daniel R.X. Lim, Wanni Chia, Laurent Renia, Ee Chee Ren, Raymond T.P. Lin, David C. Lye, Lin-Fa Wang, Lisa F.P. Ng, Barnaby E. Young
Publikováno v:
EBioMedicine, Vol 107, Iss , Pp 105275- (2024)
Summary: Background: Understanding how SARS-CoV-2 breakthrough infections impacts the breadth of immune responses against existing and pre-emergent SARS-CoV-2 strains is needed to develop an evidence-based long-term immunisation strategy. Methods: We
Externí odkaz:
https://doaj.org/article/4ec8750f0a144a5283fffeb6b9790a82
Autor:
Joanne Reekie, Henrik Stovring, Henrik Nielsen, Isik S. Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Iversen, Ahmed Basim Mustafa, Kristine Toft Petersen, Maria Ruwald Juhl, Lene Surland Knudsen, Mette Brouw Iversen, Sidsel Dahl Andersen, Fredrikke Dam Larsen, Eva Anna Marianne Baerends, Susan Olaf Lindvig, Line Dahlerup Rasmussen, Lone Wulff Madsen, Wendy Bannister, Tomas Oestergaard Jensen, Lisa Loksø Dietz, Sisse Rye Ostrowski, Lars Østergaard, Martin Tolstrup, Jens D. Lundgren, Ole Schmeltz Søgaard
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107111- (2024)
Objectives: This study aimed to compare antibody trajectories among individuals with SARS-CoV-2 hybrid and vaccine-induced immunity. Methods: Danish adults receiving three doses of BTN162b2 or mRNA-1237 were included prior to first vaccination (Day 0
Externí odkaz:
https://doaj.org/article/f20deabf34f84844be44eee61b162125
Autor:
Sayeh Ezzikouri, Raji Tajudeen, Hind Majidi, Soad Redwane, Safaa Aqillouch, Mohammed Abdulaziz, Merawi Aragaw, Mosoka Papa Fallah, Senga Sembuche, Serge Batcho, Patrick Kabwe, Elizabeth Gonese, Oumaima Laazaazia, Mohcine Elmessaoudi-Idrissi, Nadia Meziane, Abdelhakim Ainahi, M’hammed Sarih, Ahmed E. Ogwell Ouma, Abderrahmane Maaroufi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Assessing the prevalence of SARS-CoV-2 IgG positivity through population-based serological surveys is crucial for monitoring COVID-19 vaccination efforts. In this study, we evaluated SARS-CoV-2 IgG positivity within a provincial cohort to un
Externí odkaz:
https://doaj.org/article/49c9093c3394481e9ef4b8af2959bbac
Autor:
Huiling Zheng, Shenggen Wu, Wu Chen, Shaojian Cai, Meirong Zhan, Cailin Chen, Jiawei Lin, Zhonghang Xie, Jianming Ou, Wenjing Ye
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundHybrid immunity (a combination of natural and vaccine-induced immunity) provides additional immune protection against the coronavirus disease 2019 (COVID-19) reinfection. Today, people are commonly infected and vaccinated; hence, hybrid imm
Externí odkaz:
https://doaj.org/article/4a58a2c0e51c4274af3be08d25cf7db3
Autor:
Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Hiroaki Takei, Yusuke Serizawa, Hidenori Takahashi, Mio Toyama-Kousaka, Hiroto Matsuse, Masaharu Shinkai
Publikováno v:
Vaccine: X, Vol 19, Iss , Pp 100518- (2024)
Background: Our investigation focused whether infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before or after receiving the mRNA COVID-19 vaccine can increase immune protection. And we also investigated relationship of inf
Externí odkaz:
https://doaj.org/article/8f7a486f634d4f2981a7f762fc9cd8b5
Autor:
Juan P. Aguilar Ticona, Meng Xiao, Dan Li, Nivison Nery, Jr., Matt Hitchings, Emilia M. M. Andrade Belitardo, Mariam O. Fofana, Renato Victoriano, Jaqueline S. Cruz, Laise de Moraes, Icaro Morais Strobel, Jessica Jesus Silva, Ananias Sena do Aragão Filho, Guilherme S. Ribeiro, Mitermayer G. Reis, Federico Costa, Ricardo Khouri, Albert I. Ko, Derek A.T. Cummings
Publikováno v:
International Journal of Infectious Diseases, Vol 139, Iss , Pp 159-167 (2024)
Objectives: The SARS-CoV-2 BQ.1* variant rapidly spread globally in late 2022, posing a challenge due to its increased immune evasion. Methods: We conducted a prevalence survey in Brazil from November 16 to December 22, 2022, as part of a cohort stud
Externí odkaz:
https://doaj.org/article/fd398f3fc89341dc8afc3b817639966d